CAAS Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	$1.04M	Buy	43,207 +26,000	+151%	+$628K	0.11%	52
2024 Q4	$692K	Hold	17,207	–	–	0.12%	41
2024 Q3	$1.09M	Hold	17,207	–	–	0.13%	28
2024 Q2	$912K	Sell	17,207 -15,793	-48%	-$837K	0.29%	12
2024 Q1	$2.71M	Buy	+33,000	New	+$2.71M	0.2%	16